Health education in patients with a recent stroke or transient ischaemic attack: A comprehensive review

International Journal of Stroke

Volumn 6, Issue 1, 2011, Pages 67-74

  Maasland, Lisette ^a,b   Brouwer Goossensen, Dorien ^a   Den Hertog, Heleen M ^a   Koudstaal, Peter J ^a   Dippel, Diederik W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Bethesda Hospital   (Netherlands)

Author keywords

Health education; Stroke; TIA

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; LOW DENSITY LIPOPROTEIN; STATIN; THIAZIDE DIURETIC AGENT;

ATTITUDE TO ILLNESS; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CORONARY ARTERY DISEASE; COUNSELING; FEASIBILITY STUDY; FOLLOW UP; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH STATUS; HUMAN; INTERVENTION STUDY; KNOWLEDGE; LIFESTYLE MODIFICATION; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SKILL; SMOKING CESSATION; STROKE; TRANSIENT ISCHEMIC ATTACK;

CLINICAL COMPETENCE; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PATIENT EDUCATION AS TOPIC; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 78650947278     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00541.x     Document Type: Review

References (86)

1. Rothwell PM, Coull AJ, Giles MF et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363:1925-33.
2. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8:355-69.
3. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009; CD000213.
4. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25:457-507.
5. Pendlebury ST, Rothwell PM. Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke. Cerebrovasc Dis 2009; 27 (Suppl. 3): 1-11.
6. Kjellström T, Norrving B, Shatchkute A. Helsingborg declaration 2006 on European stroke strategies. Cerebrovasc Dis 2007; 23:229-41.
7. Cutler DM, Everett W. Thinking outside the pillbox - medication adherence as a priority for health care reform. N Engl J Med 2010; 362:1553-5.
8. Rankin SH, Stalling KD. Patient Education; Principles and Practise. Philadelphia, Lippincott, 2001.
9. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC. Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke 2001; 32:1884-9.
10. Mandelzweig L, Battler A, Boyko V et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006; 27:2285-93.
11. Scholte Op Reimer WJ, Dippel DW, Franke CL et al. Quality of hospital and outpatient care after stroke or transient ischemic attack: insights from a stroke survey in the Netherlands. Stroke 2006; 37:1844-9.
12. Rodgers H, Bond S, Curless R. Inadequacies in the provision of information to stroke patients and their families. Age Ageing 2001; 30:129-33.
13. Darlington AS, Dippel DW, Ribbers GM, van Balen R, Passchier J, Busschbach JJ. Coping strategies as determinants of quality of life in stroke patients: a longitudinal study. Cerebrovasc Dis 2007; 23:401-7.
14. Maasland L, Koudstaal PJ, Habbema JD, Dippel DW. Knowledge and understanding of disease process, risk factors and treatment modalities in patients with a recent TIA or minor ischemic stroke. Cerebrovasc Dis 2007; 23:435-40.
15. Kothari R, Sauerbeck L, Jauch E et al. Patients' awareness of stroke signs, symptoms, and risk factors. Stroke 1997; 28:1871-5.
16. Wellwood I, Dennis MS, Warlow CP. Perceptions and knowledge of stroke among surviving patients with stroke and their carers. Age Ageing 1994; 23:293-8.
17. Carroll C, Hobart J, Fox C, Teare L, Gibson J. Stroke in Devon: knowledge was good, but action was poor. J Neurol Neurosurg Psychiatry 2004; 75:567-71.
18. Williams LS, Bruno A, Rouch D, Marriott DJ. Stroke patients' knowledge of stroke. Influence on time to presentation. Stroke 1997; 28:912-5.
19. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-7.
20. Smith J, Forster A, Young J, On behalf of the Cochrane Group for information provision after stroke. Cochrane review: information provision for stroke patients and their caregivers. Clin Rehabil 2009; 23:195-206.
21. Maasland E, Koudstaal PJ, Habbema JD, Dippel DW. Effects of an individualized multimedia computer program for health education in patients with a recent minor stroke or transient ischemic attack - a randomized controlled trial. Acta Neurol Scand 2007; 115:41-8.
22. Lowe DB, Sharma AK, Leathley MJ. The CareFile project: a feasibility study to examine the effects of an individualised information booklet on patients after stroke. Age Ageing 2007; 36:83-9.
23. Hoffmann T, McKenna K, Worrall L, Read SJ. Randomised trial of a computer-generated tailored written education package for patients following stroke. Age Ageing 2007; 36:280-6.
24. Rodgers H, Atkinson C, Bond S, Suddes M, Dobson R, Curless R. Randomized controlled trial of a comprehensive stroke education program for patients and caregivers. Stroke 1999; 30:2585-91.
25. Mant J, Carter J, Wade DT, Winner S. The impact of an information pack on patients with stroke and their carers: a randomized controlled trial. Clin Rehabil 1998; 12:465-76.
26. Smith J, Forster A, Young J. A randomized trial to evaluate an education programme for patients and carers after stroke. Clin Rehabil 2004; 18:726-36.
27. Safer MA, Tharps QJ, Jackson TC, Leventhal H. Determinants of three stages of delay in seeking care at a medical clinic. Med Care 1979; 17:11-29.
28. Lacy CR, Suh DC, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke 2001; 32:63-9.
29. Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P. Factors influencing early admission in a French stroke unit. Stroke 2002; 33:153-9.
30. Ellis G, Rodger J, McAlpine C, Langhorne P. The impact of stroke nurse specialist input on risk factor modification: a randomised controlled trial. Age Ageing 2005; 34:389-92.
31. Goessens BM, Visseren FL, Sol BG, de Man-van Ginkel JM, van der Graaf Y. A randomized, controlled trial for risk factor reduction in patients with symptomatic vascular disease: the multidisciplinary Vascular Prevention by Nurses Study (VENUS). Eur J Cardiovasc Prev Rehabil 2006; 13:996-1003.
32. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns 2002; 48:177-87.
33. Torgerson DJ, Roland M. What is Zelen's design? BMJ 1998; 316:606.
34. Ovbiagele B, Saver JL, Fredieu A et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 2004; 35:2879-83.
35. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284:2901-6.
36. O'Mahony PG, Rodgers H, Thomson RG, Dobson R, James OF. Satisfaction with information and advice received by stroke patients. Clin Rehabil 1997; 11:68-72.
37. Larson J, Franzen-Dahlin A, Billing E, Arbin M, Murray V, Wredling R. The impact of a nurse-led support and education programme for spouses of stroke patients: a randomized controlled trial. J Clin Nurs 2005; 14:995-1003.
38. Burton C, Gibbon B. Expanding the role of the stroke nurse: a pragmatic clinical trial. J Adv Nurs 2005; 52:640-50.
39. Forster A, Young J. Specialist nurse support for patients with stroke in the community: a randomised controlled trial. BMJ 1996; 312:1642-6.
40. Yoon SS, Byles J. Perceptions of stroke in the general public and patients with stroke: a qualitative study. BMJ 2002; 324:1065-8.
41. Hux K, Rogers T, Mongar K. Common perceptions about strokes. J Community Health 2000; 25:47-65.
42. Pancioli AM, Broderick J, Kothari R et al. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA 1998; 279:1288-92.
43. Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women's Heart Disease and Stroke Campaign Task Force. Arch Fam Med 2000; 9:506-15.
44. Reeves MJ, Hogan JG, Rafferty AP. Knowledge of stroke risk factors and warning signs among Michigan adults. Neurology 2002; 59:1547-52.
45. Parahoo K, Thompson K, Cooper M, Stringer M, Ennis E, McCollam P. Stroke: awareness of the signs, symptoms and risk factors-a population-based survey. Cerebrovasc Dis 2003; 16:134-40.
46. Pandian JD, Jaison A, Deepak SS et al. Public awareness of warning symptoms, risk factors, and treatment of stroke in Northwest India. Stroke 2005; 36:644-8.
47. Muller-Nordhorn J, Nolte CH, Rossnagel K et al. Knowledge about risk factors for stroke: a population-based survey with 28, 090 participants. Stroke 2006; 37:946-50.
48. Kim JS, Yoon SS. Perspectives of stroke in persons living in Seoul, South Korea. A survey of 1000 subjects. Stroke 1997; 28:1165-9.
49. Blades LL, Oser CS, Dietrich DW et al. Rural community knowledge of stroke warning signs and risk factors. Prev Chronic Dis 2005; 2:A14.
50. Schneider AT, Pancioli AM, Khoury JC et al. Trends in community knowledge of the warning signs and risk factors for stroke. JAMA 2003; 289:343-6.
51. Becker K, Fruin M, Gooding T, Tirschwell D, Love P, Mankowski T. Community-based education improves stroke knowledge. Cerebrovasc Dis 2001; 11:34-43.
52. Ferris A, Robertson RM, Fabunmi R, Mosca L. American Heart Association and American Stroke Association national survey of stroke risk awareness among women. Circulation 2005; 111:1321-6.
53. Pontes-Neto OM, Silva GS, Feitosa MR et al. Stroke awareness in Brazil: alarming results in a community-based study. Stroke 2008; 39:292-6.
54. Vukovic V, Mikula I, Kesic MJ et al. Perception of stroke in Croatia - knowledge of stroke signs and risk factors amongst neurological outpatients. Eur J Neurol 2009; 16:1060-5.
55. Neau JP, Ingrand P, Godeneche G. Awareness within the French population concerning stroke signs, symptoms, and risk factors. Clin Neurol Neurosurg 2009; 111:659-64.
56. Nicol MB, Thrift AG. Knowledge of risk factors and warning signs of stroke. Vasc Health Risk Manag 2005; 1:137-47.
57. Sug Yoon S, Heller RF, Levi C, Wiggers J, Fitzgerald PE. Knowledge of stroke risk factors, warning symptoms, and treatment among an Australian urban population. Stroke 2001; 32:1926-30.
58. Silver FL, Rubini F, Black D, Hodgson CS. Advertising strategies to increase public knowledge of the warning signs of stroke. Stroke 2003; 34:1965-8.
59. Stern EB, Berman M, Thomas JJ, Klassen AC. Community education for stroke awareness: an efficacy study. Stroke 1999; 30:720-3.
60. Marx JJ, Gube C, Faldum A et al. An educational multimedia campaign improves stroke knowledge and risk perception in different stroke risk groups. Eur J Neurol 2009; 16:612-8.
61. Hodgson C, Lindsay P, Rubini F. Can mass media influence emergency department visits for stroke? Stroke 2007; 38:2115-22.
62. Kleindorfer D, Khoury J, Broderick JP et al. Temporal trends in public awareness of stroke. Warning signs, risk factors, and treatment. Stroke 2009; 40:2502-6.
63. van Leijden AJ, Wimmers RH, Hinlopen CH, Franke CL. Public stroke knowledge and care-seeking intention 2004-2008. The long term impact of an educational mass media campaign in the Netherlands. Cerebrovasc Dis 2009; 27 (Suppl. 6): 68.
64. Marx JJ, Nedelmann M, Haertle B, Dieterich M, Eicke BM. An educational multimedia campaign has differential effects on public stroke knowledge and care-seeking behavior. J Neurol 2008; 255:378-84.
65. Mikulik R, Bunt L, Hrdlicka D, Dusek L, Vaclavik D, Kryza J. Calling 911 in response to stroke: a nationwide study assessing definitive individual behavior. Stroke 2008; 39:1844-9.
66. Anderson BE, Rafferty AP, Lyon-Callo S, Fussman C, Reeves MJ. Knowledge of tissue plasminogen activator for acute stroke among Michigan adults. Stroke 2009; 40:2564-7.
67. WRITING GROUP, Lloyd-Jones D, Adams R et al. Heart disease and stroke statistics - 2009 update: a report from the american heart association statistics committee and stroke statistics subcommittee. Circulation 2009; 119:e21-181.
68. Kayaniyil S, Ardern CI, Winstanley J et al. Degree and correlates of cardiac knowledge and awareness among cardiac inpatients. Patient Educ Couns 2009; 75:99-107.
69. Dracup K, McKinley S, Doering LV et al. Acute coronary syndrome: what do patients know? Arch Intern Med 2008; 168:1049-54.
70. Zerwic JJ, King KB, Wlasowicz GS. Perceptions of patients with cardiovascular disease about the causes of coronary artery disease. Heart Lung 2003; 26:92-8.
71. McKinley S, Dracup K, Moser DK et al. The effect of a short one-on-one nursing intervention on knowledge, attitudes and beliefs related to response to acute coronary syndrome in people with coronary heart disease: a randomized controlled trial. Int J Nurs Stud 2009; 46:1037-46.
72. Buckley T, McKinley S, Gallagher R, Dracup K, Moser DK, Aitken LM. The effect of education and counselling on knowledge, attitudes and beliefs about responses to acute myocardial infarction symptoms. Eur J Cardiovasc Nurs 2007; 6:105-11.
73. Cohen J. A power primer. Psychol Bull 1992; 112:155-9.
74. Beranova E, Sykes C. A systematic review of computer-based softwares for educating patients with coronary heart disease. Patient Educ Couns 2007; 66:21-8.
75. Simoons ML, Serruys PW, Van den Brand M et al. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol 1986; 7:717-28.
76. Meischke H, Ho MT, Eisenberg MS, Schaeffer SM, Larsen MP. Reasons patients with chest pain delay or do not call 911. Ann Emerg Med 1995; 25:193-7.
77. Luepker RV, Raczynski JM, Osganian S et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) trial. JAMA 2000; 284:60-7.
78. Dracup K, McKinley S, Riegel B et al. A randomized clinical trial to reduce patient prehospital delay to treatment in acute coronary syndrome. Circ Cardiovasc Qual Outcomes 2009; 2:524-32.
79. Kotseva K, Wood D, De Backer G et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. [Article]. Eur J Cardiovas Prev Rehabil 2009; 16:121-37.
80. Giannuzzi P, Temporelli PL, Marchioli R et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL Study, a multicenter, randomized controlled trial from the Italian cardiac rehabilitation network. Arch Intern Med 2008; 168:2194-204.
81. Wood DA, Kotseva K, Connolly S et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008; 371:1999-2012.
82. Harmsen P, Lappas G, Rosengren A, Wilhelmsen L. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden. Stroke 2006; 37:1663-7.
83. van Wijk I, Kappelle LJ, van Gijn J et al. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet 2005; 365:2098-104.
84. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:7-22.
85. Amarenco P, Goldstein LB, Szarek M et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2007; 38:3198-204.
86. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6, 105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-41.